The p53 isoforms are differentially modified by Mdm2

被引:32
|
作者
Camus, Suzanne [2 ]
Menendez, Sergio [2 ]
Fernandes, Kenneth [1 ]
Kua, Nelly [2 ]
Liu, Geng [3 ]
Xirodimas, Dimitris P. [3 ]
Lane, David P. [2 ]
Bourdon, Jean-Christophe [1 ]
机构
[1] Univ Dundee, Coll Med, Ctr Oncol & Mol Med, Dundee, Scotland
[2] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore
[3] Ctr Rech Biochim Macromol, UMR 5237, Montpellier, France
关键词
p53; isoform; Mdm2; degradation; ubiquitination; neddylation; nedd8; splice; nutlin; INFLUENCES SIRNA EFFICACY; P53-RELATED PROTEIN P73; TUMOR-SUPPRESSOR P53; C-TERMINUS; IN-VIVO; TRANSCRIPTIONAL ACTIVITY; FUNCTIONAL-ANALYSIS; STABILITY CONTROL; ONCOPROTEIN MDM2; DNA-DAMAGE;
D O I
10.4161/cc.20119
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The discovery that the single p53 gene encodes several different p53 protein isoforms has initiated a flurry of research into the function and regulation of these novel p53 proteins. Full-length p53 protein level is primarily regulated by the E3-ligase Mdm2, which promotes p53 ubiquitination and degradation. Here, we report that all of the novel p53 isoforms are ubiquitinated and degraded to varying degrees in an Mdm2-dependent and -independent manner, and that high-risk human papillomavirus can degrade some but not all of the novel isoforms, demonstrating that full-length p53 and the p53 isoforms are differentially regulated. In addition, we provide the first evidence that Mdm2 promotes the NEDDylation of p53 beta. Altogether, our data indicates that Mdm2 can distinguish between the p53 isoforms and modify them differently.
引用
收藏
页码:1646 / 1655
页数:10
相关论文
共 50 条
  • [41] Reactivation of p53 via MDM2 inhibition
    E S Kim
    J M Shohet
    Cell Death & Disease, 2015, 6 : e1936 - e1936
  • [42] Relevance of the p53–MDM2 axis to aging
    Danyi Wu
    Carol Prives
    Cell Death & Differentiation, 2018, 25 : 169 - 179
  • [43] Regulation of p53 by Mdm2: Fate is in the numbers
    Shmueli, A
    Oren, M
    MOLECULAR CELL, 2004, 13 (01) : 4 - 5
  • [44] Stabilization of the MDM2 oncoprotein by mutant p53
    Peng, YH
    Chen, LH
    Li, CG
    Lu, WG
    Agrawal, S
    Chen, JD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (09) : 6874 - 6878
  • [45] Mdm2 and MdmX: Partners in p53 Destruction
    Manfredi, James J.
    CANCER RESEARCH, 2021, 81 (07) : 1633 - 1634
  • [46] Mdm2: keeping p53 under control
    Jacques Piette
    Henry Neel
    Vincent Maréchal
    Oncogene, 1997, 15 : 1001 - 1010
  • [47] p53 and MDM2: Antagonists or Partners in Crime?
    Eischen, Christine M.
    Lozano, Guillermina
    CANCER CELL, 2009, 15 (03) : 161 - 162
  • [48] Regulation of p53 and MDM2 activity by MTBP
    Brady, M
    Vlatkovic, N
    Boyd, MT
    MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (02) : 545 - 553
  • [49] Transcription factors that interact with p53 and Mdm2
    Inoue, Kazushi
    Fry, Elizabeth A.
    Frazier, Donna P.
    INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (07) : 1577 - 1585
  • [50] Inhibition of p53 degradation by Mdm2 acetylation
    Wang, XJ
    Taplick, J
    Geva, N
    Oren, M
    FEBS LETTERS, 2004, 561 (1-3): : 195 - 201